232 related articles for article (PubMed ID: 35035875)
1. Lipid ratios and obesity indices are effective predictors of metabolic syndrome in women with polycystic ovary syndrome.
Kałużna M; Czlapka-Matyasik M; Kompf P; Moczko J; Wachowiak-Ochmańska K; Janicki A; Samarzewska K; Ruchała M; Ziemnicka K
Ther Adv Endocrinol Metab; 2022; 13():20420188211066699. PubMed ID: 35035875
[TBL] [Abstract][Full Text] [Related]
2. Lipid Accumulation Product (LAP) and Visceral Adiposity Index (VAI) as Markers of Insulin Resistance and Metabolic Associated Disturbances in Young Argentine Women with Polycystic Ovary Syndrome.
Abruzzese GA; Cerrrone GE; Gamez JM; Graffigna MN; Belli S; Lioy G; Mormandi E; Otero P; Levalle OA; Motta AB
Horm Metab Res; 2017 Jan; 49(1):23-29. PubMed ID: 27571188
[TBL] [Abstract][Full Text] [Related]
3. The impact of lipid accumulation product (LAP) and visceral adiposity index (VAI) on clinical, hormonal and metabolic parameters in lean women with polycystic ovary syndrome.
Anik Ilhan G; Yildizhan B; Pekin T
Gynecol Endocrinol; 2019 Mar; 35(3):233-236. PubMed ID: 30303693
[TBL] [Abstract][Full Text] [Related]
4. Body fat indices as effective predictors of insulin resistance in obese/non-obese polycystic ovary syndrome women in the Southwest of China.
Huang X; Wang Q; Liu T; Pei T; Liu D; Zhu H; Huang W
Endocrine; 2019 Jul; 65(1):81-85. PubMed ID: 30924083
[TBL] [Abstract][Full Text] [Related]
5. The Visceral Adiposity Index (VAI) and Lipid Accumulation Product (LAP) Are Predictors of Insulin Resistance and Hyperandrogenaemia in Obesity/Overweight Women with Polycystic Ovary Syndrome.
Wang H; Cao H; Cao J; Zhang L
Biomed Res Int; 2023; 2023():1508675. PubMed ID: 36814799
[TBL] [Abstract][Full Text] [Related]
6. Value of the triglyceride-glucose index and non-traditional blood lipid parameters in predicting metabolic syndrome in women with polycystic ovary syndrome.
Zhang L; Wang H; Ma Q; Liu Y; Chen A; Lu J; Ren L
Hormones (Athens); 2023 Jun; 22(2):263-271. PubMed ID: 36790635
[TBL] [Abstract][Full Text] [Related]
7. Lipid Accumulation Product Better Predicts Metabolic Status in Lean Polycystic Ovary Syndrome than that by Visceral Adiposity Index.
Banu H; Morshed MS; Sultana T; Shah S; Afrine S; Hasanat MA
J Hum Reprod Sci; 2022; 15(1):27-33. PubMed ID: 35494190
[TBL] [Abstract][Full Text] [Related]
8. The role of the visceral adiposity index in the assessment of metabolic syndrome of polycystic ovary syndrome patients: a new anthropometric index.
Rocha ALL; Baêta T; Nazareth IR; Costa JM; Caporalli JD; Oliveira MA; Couto MG; Azevedo RC; Comim FV; Oliveira FR; Reis FM; Cândido AL
Arch Gynecol Obstet; 2024 Apr; 309(4):1643-1649. PubMed ID: 38321350
[TBL] [Abstract][Full Text] [Related]
9. Fetuin-A and Its Association with Anthropometric, Atherogenic, and Biochemical Parameters and Indices among Women with Polycystic Ovary Syndrome.
Kulik-Kupka K; Jabczyk M; Nowak J; Jagielski P; Hudzik B; Zubelewicz-Szkodzińska B
Nutrients; 2022 Sep; 14(19):. PubMed ID: 36235688
[TBL] [Abstract][Full Text] [Related]
10. Utility of Visceral Adiposity Index and Lipid Accumulation Products to Define Metabolically-Unhealthy Polycystic Ovary Syndrome in Asian Indian Women - A Cross Sectional Study.
Shreenidhi RA; Mahey R; Rajput M; Cheluvaraju R; Upadhyay AD; Sharma JB; Kachhawa G; Bhatla N
J Hum Reprod Sci; 2024; 17(1):50-57. PubMed ID: 38665608
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic performance using obesity and lipid-related indices and atherogenic index of plasma to predict metabolic syndrome in the adult sudanese population.
Mosad AS; Elfadil GA; Elhassan SH; Elbashir ZA; S A Husain NEO; Karar T; Elfaki EM
Niger J Clin Pract; 2023 May; 26(5):617-624. PubMed ID: 37357479
[TBL] [Abstract][Full Text] [Related]
12. The Role of Visceral Adiposity Index as Predictor of Metabolic Syndrome in Obese and Nonobese Women with Polycystic Ovary Syndrome.
de Medeiros SF; de Medeiros MAS; Barbosa BB; Yamamoto MMW
Metab Syndr Relat Disord; 2021 Feb; 19(1):18-25. PubMed ID: 32845813
[No Abstract] [Full Text] [Related]
13. Metabolic Deregulations in Patients with Polycystic Ovary Syndrome.
Jabczyk M; Nowak J; Jagielski P; Hudzik B; Kulik-Kupka K; Włodarczyk A; Lar K; Zubelewicz-Szkodzińska B
Metabolites; 2023 Feb; 13(2):. PubMed ID: 36837921
[TBL] [Abstract][Full Text] [Related]
14. Visceral Adiposity Index and Lipid Accumulation Product as diagnostic markers of Metabolic Syndrome in South Indians with Polycystic Ovary Syndrome.
Naghshband Z; Kumar L; Mandappa S; Niranjana Murthy AS; Malini SS
J Hum Reprod Sci; 2021; 14(3):234-243. PubMed ID: 34759612
[TBL] [Abstract][Full Text] [Related]
15. Association of measures of central fat accumulation indices with body fat distribution and metabolic, hormonal, and inflammatory parameters in women with polycystic ovary syndrome.
Ribeiro VB; Kogure GS; Lopes IP; Silva RC; Pedroso DCC; Ferriani RA; Furtado CLM; Reis RMD
Arch Endocrinol Metab; 2019 Jul; 63(4):417-426. PubMed ID: 31365630
[TBL] [Abstract][Full Text] [Related]
16. Comparison of various adiposity indexes in women with polycystic ovary syndrome and normo-ovulatory non-hirsute women: a population-based study.
Ramezani Tehrani F; Minooee S; Azizi F
Eur J Endocrinol; 2014 Aug; 171(2):199-207. PubMed ID: 24816947
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein A-I and B levels, dyslipidemia and metabolic syndrome in south-west Chinese women with PCOS.
Zhang J; Fan P; Liu H; Bai H; Wang Y; Zhang F
Hum Reprod; 2012 Aug; 27(8):2484-93. PubMed ID: 22674204
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of Different Obesity Metabolic Indexes and their Correlation with Insulin Resistance in Patients with Polycystic Ovary Syndrome.
Feng Y; Li M; Li X; Tang Q; Li X; Ji X; Tian W; Zhang H
Reprod Sci; 2024 Apr; ():. PubMed ID: 38649666
[TBL] [Abstract][Full Text] [Related]
19. [Relationship between the triglyceride/high-density lipoprotein-cholesterol ratio, insulin resistance index and cardiometabolic risk factors in women with polycystic ovary syndrome].
Roa Barrios M; Arata-Bellabarba G; Valeri L; Velázquez-Maldonado E
Endocrinol Nutr; 2009 Feb; 56(2):59-65. PubMed ID: 19627713
[TBL] [Abstract][Full Text] [Related]
20. Lipid accumulation product and triglycerides/glucose index are useful predictors of insulin resistance.
Mazidi M; Kengne AP; Katsiki N; Mikhailidis DP; Banach M
J Diabetes Complications; 2018 Mar; 32(3):266-270. PubMed ID: 29395839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
